Identification of antibody targets associated with lower HIV viral load and viremic control

We identified HIV antibody targets associated with lower VL and HIV controller status 1-2 years after infection. Robust aggregate responses to these targets and broad antibody reactivity across the HIV genome were also associated with lower VL and controller status. These findings provide novel insights into the relationship between humoral immunity and viral containment that could help inform the design of antibody-based approaches for reducing HIV VL.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2024-09-17
DOI
https://doi.org/10.1371/journal.pone.0305976
Citations
1
Primary Topic
HIV Research and Treatment
Type
article
Field-Weighted Citation Impact
0.29

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Identification of antibody targets associated with lower HIV viral load and viremic control

Sarah E. Hudelson, Oliver Laeyendecker, William Clarke, William R. Morgenlander et al.
1 citations
PLoS ONE
HIV Research and Treatment
0.29
article

Identification of antibody targets associated with lower HIV viral load and viremic control

Sarah E. Hudelson, Oliver Laeyendecker, William Clarke, William R. Morgenlander, Peter Bock, Sue‐Ann Meehan, Estelle Piwowar‐Manning, Helen Ayles, Kwame Shanaube, Autumn Breaud, Barry R. Kosloff, Kai Kammers, H. Benjamin Larman, Wendy Grant‐McAuley, Sarah Fidler, Ayana Moore, Susan H. Eshleman, Ingo Ruczinski, Richard Hayes, Manjusha Thakar, Anneen van Deventer
article en
1 citations

Abstract

We identified HIV antibody targets associated with lower VL and HIV controller status 1-2 years after infection. Robust aggregate responses to these targets and broad antibody reactivity across the HIV genome were also associated with lower VL and controller status. These findings provide novel insights into the relationship between humoral immunity and viral containment that could help inform the design of antibody-based approaches for reducing HIV VL.

PLoS ONEVol. 19(9)
Family Health International 360 (US), National Institutes of Health (US), Desmond Tutu HIV Foundation (ZA), Johns Hopkins University (US), Stellenbosch University (ZA), Johns Hopkins Medicine (US), University of Zambia (ZM), London School of Hygiene & Tropical Medicine (GB), National Institute of Allergy and Infectious Diseases (US), Zambart (ZM), Sidney Kimmel Comprehensive Cancer Center (US), Imperial College London (GB)
Bill and Melinda Gates Foundation, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, U.S. President’s Emergency Plan for AIDS Relief, Department for International Development, UK Government, European Commission, Department for International Development, National Institutes of Health, Medical Research Council, National Institute of Mental Health, National Institute on Drug Abuse, National Institute of General Medical Sciences, National Institute of Allergy and Infectious Diseases, NHLBI Division of Intramural Research, European and Developing Countries Clinical Trials Partnership
Good health and well-being
Openalex Percentile: Top 41%
HIV Research and Treatment
0.29
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.